These can include thyroid cancer or problems with the gallbladder, or other adverse events
Zhou J, Livak MF, Bernier M, Muller DC, Carlson OD, Elahi D, Maudsley S, Egan JM (2007) Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets
If you have spent eight or more weeks at each dose increase, tried dietary modifications, used anti-nausea medications, and still cannot tolerate the weekly injection at a dose that provides therapeutic benefit, split dosing represents a logical next step before abandoning semaglutide entirely
Enhancing Your Results with Support While timing your injection is a practical step, long-term metabolic health often requires a multi-faceted approach
Your healthcare provider will help you determine the appropriate duration of treatment
American Academy of Allergy Asthma and Immunology